Stille AB
STO:STIL
Stille AB
Operating Expenses
Stille AB
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Stille AB
STO:STIL
|
Operating Expenses
-kr180.7m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-20%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Operating Expenses
-kr4.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Operating Expenses
-kr453.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Operating Expenses
-kr309.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-12%
|
|
|
Getinge AB
STO:GETI B
|
Operating Expenses
-kr12.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Operating Expenses
-kr3.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Stille AB
Glance View
Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
See Also
What is Stille AB's Operating Expenses?
Operating Expenses
-180.7m
SEK
Based on the financial report for Dec 31, 2024, Stille AB's Operating Expenses amounts to -180.7m SEK.
What is Stille AB's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-20%
Over the last year, the Operating Expenses growth was -107%. The average annual Operating Expenses growth rates for Stille AB have been -44% over the past three years , -36% over the past five years , and -20% over the past ten years .
You don't have any saved screeners yet